Prosecution Insights
Last updated: April 19, 2026

Centro De Inmunología Molecular

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18266486 USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING PROTECTIVE IMMUNITY CHEN, STACY BROWN 1672 Non-Final OA Jun 09, 2023
18021731 COMPOSITIONS OF SARS-COV-2 VACCINES BASED ON THE RECEPTOR BINDING DOMAIN, EXPRESSED AS A DIMER, AND THE OUTER MEMBRANE VESICLE OF MENINGOCOCCAL GROUP B BACTERIA CHEN, STACY BROWN 1672 Non-Final OA Feb 16, 2023
18018156 USE OF EPIDERMAL GROWTH FACTOR DEPLETING AGENTS IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MERTZ, PREMA MARIA 1674 Non-Final OA Jan 26, 2023

Managing Centro De Inmunología Molecular's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month